Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticular Carriers For Ocular Drug Delivery

A. Sánchez, M. J. Alonso
Published 2006 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1211/0022357022476
The potential of chitosan in ocular drug delivery
M. Alonso (2003)
10.1016/0014-4835(90)90170-Y
Visualization of hyaluronic acid in the anterior segment of rabbit and monkey eyes.
E. Lütjen-Drecoll (1990)
10.1016/0039-6257(84)90168-1
Ophthalmic drug delivery systems
J. Shell (1984)
10.1023/A:1019842024814
Synthesis of Pegylated Immunonanoparticles
J. Olivier (2004)
10.1211/0022357023835
Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene
C. Bucolo (2004)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
The Dry Eye: A Comprehensive Guide
M. Lemp (1992)
10.1016/S0928-0987(03)00178-7
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
A. M. de Campos (2003)
10.1002/JPS.2600721108
Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors
Hong-Shian Huang (1983)
10.1016/0002-9610(70)90175-3
The discovery of a potent pure chemical wound-healing accelerator.
J. F. Prudden (1970)
10.3109/02652048609031575
Ocular drug delivery of progesterone using nanoparticles.
V. Li (1986)
10.3109/02713688509025154
Ocular pharmacology of sulfonamides: the cornea as barrier and depot.
T. Maren (1985)
10.1023/B:PHAM.0000022411.47059.76
The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers
Mohamed G. Qaddoumi (2004)
10.1016/S0142-9612(01)00284-8
Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats.
M. Merodio (2002)
10.1016/0169-409X(95)00012-V
Ocular drug delivery conventional ocular formulations
John C. Lang (1995)
10.1007/s004170050321
Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit
Maria Victoria de Rojas Silva (1999)
10.1016/S0142-9612(02)00080-7
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
R. Pignatello (2002)
10.3109/02652049109021873
Studies on the transport pathway of PBCA nanoparticles in ocular tissues.
A. Zimmer (1991)
10.1016/0144-8617(96)00003-3
Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme
Ragnhild J. Nordtveit (1996)
10.1016/S0147-5975(79)80054-7
The fungicidal effect of chitosan on fungi of varying cell wall composition
C. R. Allan (1979)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1016/S0169-409X(01)00200-9
Biodegradable microspheres for vitreoretinal drug delivery.
R. Herrero-Vanrell (2001)
10.1136/bjo.75.1.22
Lectin binding sites in normal, scarred, and lattice dystrophy corneas.
P. Bishop (1991)
10.1201/9781003067542
Microparticulate systems for the delivery of proteins and vaccines
S. Cohen (1996)
10.1001/ARCHOPHT.117.9.1250
Suture loop to aid in ganciclovir implant removal.
M. Maccumber (1999)



This paper is referenced by
Ispitivanje bioadhezivnosti lecitinsko-kitozanskih nanočestica s melatoninom
M. Brkić (2015)
A REVIEW O CHITOSA BASED AOPARTICLE AS A EW OCULAR DRUG DELIVERY
M. Shivashankar (2011)
10.1097/ICO.0b013e3181bd9eee
Ocular Tolerance to a Topical Formulation of Hyaluronic Acid and Chitosan-Based Nanoparticles
L. Contreras-Ruiz (2010)
10.1038/gt.2008.16
Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
M. Fuente (2008)
10.1016/J.BIOMATERIALS.2006.11.028
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
10.1007/978-3-319-29346-2_18
Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye
V. Pillay (2016)
10.1007/978-3-319-56979-6_11
Nanotechnology in Ophthalmology
N. Petrovic (2018)
10.1038/gt.2012.56
A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model
L. Contreras-Ruiz (2013)
10.1016/j.preteyeres.2010.08.002
Applications of nanoparticles in ophthalmology
Y. Diebold (2010)
10.1517/17425247.2011.542142
Ocular drug delivery – a look towards nanobioadhesives
L. D. du Toit (2011)
10.1016/j.addr.2009.11.026
Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
M. de la Fuente (2010)
10.1002/jps.23650
Design of an anti-inflammatory composite nanosystem and evaluation of its potential for ocular drug delivery.
Lisa C. du Toit (2013)
PREPARATION AND CHARACTERIZATION OF NANO CARRIERS
(2016)
10.3797/SCIPHARM.CESPT.8.PNM19
Bioavailability of Dexamethasone from Nonionic Surfactant/Chitosan Micelle System
I. Pepić (2010)
10.3797/scipharm.cespt.8.PDD01
Interaction of β-Cyclodextrin with DNA-Bases
Elisabeth Liedl (2010)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
10.1007/978-3-319-95807-1_7
Nano/Microparticles for Retina and Posterior Diseases
A. Patel (2018)
10.1517/17425240902762818
Chitosan nanoparticles for drug delivery to the eye
P. Paolicelli (2009)
10.1002/jps.22137
A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation.
Ivan Pepić (2010)
EFFECT OF MOLECULAR WEIGHT AND DEGREE OF ACETYLATION ON THE PHYSICOCHEMICAL CHARACTERISTICS OF CHITOSAN NANOPARTICLES
M. GoycooleaF. (2007)
10.1080/09273948.2017.1333622
Ocular Self-Microemulsifying Drug Delivery System of Prednisolone Improves Therapeutic Effectiveness in the Treatment of Experimental Uveitis
R. Tiwari (2019)
10.1080/17425247.2016.1213240
Current advances in the treatment of neovascular age-related macular degeneration
V. Villegas (2017)
Semantic Scholar Logo Some data provided by SemanticScholar